Skip to content

US · PASW · APPAREL - MANUFACTURERS

Ping An Biomedical Co., Ltd. (PASW) intrinsic value and stock valuation

$1.13as of 2026-11-21 · Mkt cap 2.38M

Data updated · price as of 2026-11-21

IC valuationIntrinsic value, upside vs price and the fair-value band are available to Pro members.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Ping An Biomedical Co., Ltd. DCF and intrinsic value

InvestorsCraft values PASW with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from PASW’s statements →

Consumer Cyclical · Apparel - Manufacturers Hong Kong newbrandcashmere.com

How the business is doing

Fiscal 2021–2025, USD

Revenue
$34.2M
20212025
Net income
-$-12.83M
20212025
Free cash flow
-$-6.43M
20212025
Total equity
$45.2M
20212025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2021–2025, USD
20252024202320222021
Revenue$34.2M$87.6M$82.6M$114.6M$99.5M
Operating income-$-14.7M-$0.00$610K$10.8M$8.27M
Net income-$-12.83M-$-1.28M-$-990K$7.23M$5.21M
EPSd——-$-48.29K$352.7K$378.9K
Operating cash flow-$-6.43M$14.6M-$-6.08M$21.1M-$-31.37M
Capital expenditure$0.00$0.00$0.00-$-20K-$-30K
Free cash flow-$-6.43M$14.6M-$-6.08M$21.1M-$-31.4M
Total assets$68.4M$56.9M$79.8M$82M$73.7M
Total debt$10.5M$10.8M$43M$35.6M$29M
Net debt$9.3M$10.7M$42.4M$34.4M$28.9M
Total equity$45.2M-$-7.19M-$-5.86M$4.6M-$-2.06M
Cash and short-term investments$1.17M$130K$590K$1.17M$110K
Income statement
20252024202320222021
Revenue$34.2M$87.6M$82.6M$114.6M$99.5M
Cost of revenue$33.2M$82.2M$78.3M$100.4M$85.3M
Gross profit$950K$5.42M$4.24M$14.1M$14.3M
Research and development expenses$0.00$0.00$0.00$0.00$0.00
Selling, general and administrative expenses$6.3M$4.85M$3.21M$3.11M$3.37M
Other expenses$9.35M$570K$420K$220K$2.63M
Operating expenses$15.7M$5.42M$3.63M$3.33M$6M
Cost and expenses$48.9M$87.6M$82M$103.7M$91.3M
Interest income$330K$0.00$160K$40K$0.00
Interest expense$310K$710K$1.74M$1.57M$1.36M
Depreciation and amortization$10K$450K$420K$410K$390K
Ebitda-$-14.37M$470K$2.2M$11.6M$9.57M
Operating income-$-14.7M-$0.00$610K$10.8M$8.27M
Total other income/expenses, net$20K-$-680K-$-570K-$-1.19M-$-450K
Income before tax-$-14.68M-$-680K$40K$9.63M$7.82M
Income tax expense-$-1.86M$600K$1.04M$2.4M$2.61M
Net income-$-12.83M-$-1.28M-$-990K$7.23M$5.21M
Weighted average shares outstanding$0.00$0.00$20.5M$20.5M$13.8M
Weighted average diluted shares outstanding$0.00$0.00$20.5M$20.5M$13.8M
Balance sheet
20252024202320222021
Cash and short-term investments$1.17M$130K$590K$1.17M$110K
Net receivables$17.3M$40.5M$61.1M$67.6M$49.8M
Inventory$440K$130K$3.19M$4.63M$16M
Total current assets$63.7M$53.3M$76.6M$79M$70.4M
Property, plant and equipment, net$470K$820K$540K$180K$570K
Goodwill and intangible assets$0.00$0.00$0.00$0.00$0.00
Long-term investments$0.00$0.00$0.00$0.00$0.00
Total non-current assets$4.72M$3.54M$3.27M$2.91M$3.34M
Total assets$68.4M$56.9M$79.8M$82M$73.7M
Accounts payable$9.41M$15.1M$9.27M$18M$7.14M
Short-term debt$10.4M$10.4M$42.9M$35.6M$28.9M
Deferred revenue$70K$1.67M$530K$270K$1.67M
Total current liabilities$23.1M$63.6M$85.6M$77.4M$75.7M
Long-term debt$100K$460K$70K$0.00$70K
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$100K$460K$70K$0.00$70K
Capital lease obligations$470K$810K$460K$70K$460K
Total liabilities$23.2M$64M$85.7M$77.4M$75.8M
Common stock$10K$10K$10K$10K$10K
Retained earnings-$-21.05M-$-8.22M-$-6.58M$4.45M-$-2.07M
Accumulated other comprehensive income (loss)$70K$1.02M$710K$140K$10K
Total equity$45.2M-$-7.19M-$-5.86M$4.6M-$-2.06M
Total investments$0.00$0.00$0.00$0.00$0.00
Total debt$10.5M$10.8M$43M$35.6M$29M
Net debt$9.3M$10.7M$42.4M$34.4M$28.9M
Cash flow statement
20252024202320222021
Net income-$-12.83M-$-1.28M-$-990K$7.23M$5.21M
Depreciation and amortization$10K$10K$30K$20K$390K
Stock-based compensation$0.00$0.00$0.00$0.00$0.00
Change in working capital-$-1.41M$15.8M-$-5.14M$14M-$-38.66M
Accounts receivable$14.2M$6.53M$9.88M-$-7.79M-$-28.89M
Inventory-$-310K$3.06M$1.44M$11.4M-$-10.18M
Accounts payable-$-5.64M$5.78M-$-8.76M$10.9M$5.19M
Net cash provided by operating activities-$-6.43M$14.6M-$-6.08M$21.1M-$-31.37M
Investments in property, plant and equipment$0.00$0.00$0.00-$-20K-$-30K
Acquisitions, net$0.00$0.00$0.00$0.00$0.00
Net cash used for investing activities$0.00$15M-$-3.37M-$-30.26M-$-30K
Common stock issued$108.2M$0.00$0.00$10K$0.00
Common stock repurchased$0.00$0.00$0.00$0.00$0.00
Dividends paid$0.00-$-320K-$-9.6M-$-4.83M$0.00
Net cash used for financing activities$43.7M-$-30.09M$8.87M$10.2M$31.5M
Net change in cash$36.6M-$-460K-$-570K$1.06M-$-50K
Cash at end of period$36.7M$130K$590K$1.17M$110K
Operating cash flow-$-6.43M$14.6M-$-6.08M$21.1M-$-31.37M
Capital expenditure$0.00$0.00$0.00-$-20K-$-30K
Free cash flow-$-6.43M$14.6M-$-6.08M$21.1M-$-31.4M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Ping An Biomedical Co., Ltd.

        Ping An Biomedical Co., Ltd. delivers comprehensive supply chain management services tailored for the clothing sector. The company furnishes integrated solutions to its clients, covering a wide spectrum of offerings from initial yarn products and various textiles to fully manufactured garments. Its operations are organized into two primary divisions: Yarns and Finished Garments. Established in 2013 by Yuk Yin Li and Sek Yan Ko, the firm's main office is situated in Hong Kong.

        CEO
        Pijun Liu
        Employees
        7
        Beta
        2.24

        Explore

        Frequently asked questions

        What is the intrinsic value of Ping An Biomedical Co., Ltd. (PASW)?

        InvestorsCraft does not currently publish an intrinsic value for PASW. How the IC value is calculated.

        Is PASW undervalued?

        InvestorsCraft does not publish an undervaluation signal for PASW at this time.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.